Inflammatory cytokines are significantly elevated in MDS patients with SF3B1 mutations, impairing the ecotopic function of HSCs and leading to suppression of normal hematopoietic function, which is associated with a poor prognosis (33, 50). Here, SF3B1 is linked to myelodysplastic syndrome.